Zevra Therapeutics

ZVRANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$687.664 M

$11.58 -0.77%

Close of 22 Sept 2026

Revenue

—

Not reported

Earnings

$83.2M

#1374 by earnings

Shares outstanding

59,383,781

Latest filing cover page

P/E ratio

8.3

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#184Collegium PharmaceuticalCOLL$741.6M
#185MapLight TherapeuticsMPLT$703.4M
#186Zevra TherapeuticsZVRA$687.7M
#187Sagimet BiosciencesSGMT$683.0M
#188NeurogeneNGNE$672.4M

What if Zevra Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.2T

$509,128.40

Per share 43,966× higher

Bitcoin $1.74T

$29,328.80

Per share 2,533× higher

Nvidia $5.52T

$92,883.39

Per share 8,021× higher

Or at a round number

$1.00B $2.00B $5.00B $10.0B

Where these numbers come from

Share counts and financials for Zevra Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.